通过转录和表观遗传装甲对CAR-T细胞进行超载
Diyuan Qin1,2, Yanna Lei3, Pei Shu4
1Cancer Center, Clinical Trial Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Theranostics
|March 17, 2025
概括
卡特-T疗法对固体瘤有希望,但T细胞枯竭限制了疗效. 向转录因子和表观遗传修饰剂可以增强CAR-T细胞的持久性和功能,以改善癌症治疗.
科学领域:
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
- 在瘤学瘤学.
背景情况:
- 在血液癌症中成功的CAR-T疗法在固体瘤中面临挑战.
- T细胞耗尽和有限的持久性阻碍了CAR-T对固体瘤的疗效.
研究的目的:
- 审查提高固体瘤中CAR-T疗法疗效的策略.
- 探索转录因子和表观遗传修饰在CAR-T细胞功能中的作用.
- 通过转录和表观遗传干预提供改善CAR-T疗法的框架.
主要方法:
- 对T细胞功能的转录因子和表观遗传调节体研究的文献综述.
- 对关键的转录因子 (例如c-Jun,FOXO1) 和表观遗传修饰剂 (例如TET2,DNMT3A) 的分析.
- 探索它们的机制,目标和对T细胞记忆形成和效应器功能的影响.
主要成果:
- 像c-Jun和FOXO1这样的转录因子增强T细胞效应器功能,减少疲劳.
- 表观遗传调节者,如TET2和DNMT3A,影响形成记忆T细胞子集.
- 突出了这些因素之间的相互联系及其对CAR-T业绩的下游影响.
结论:
- 转录和表观遗传修改为超级充电CAR-T疗法提供了一个有希望的途径.
- 针对特定因素可以改善T细胞的持久性,功能和记忆形成,用于固体瘤治疗.
- 对这些机制的进一步研究可以为更广泛的临床应用优化CAR-T疗法.
相关概念视频
Tumor Immunotherapy
457
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
457
Chromatin Modification in iPS Cells
1.6K
Chromatin modification alters gene expression; therefore, scientists can add histone-modifying enzymes, histone variants, and chromatin remodeling complexes to somatic cells to aid reprogramming into pluripotent stem (iPS) cells.
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
1.6K
Somatic to iPS Cell Reprogramming
2.2K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.2K
T Cell Activation and Clonal Selection
620
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
620
Methods of Nuclear Reprogramming
1.8K
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
1.8K
Forced Transdifferentiation
1.9K
Transdifferentiation, also known as lineage reprogramming, was first discovered by Selman and Kafatos in 1974 in silkmoths. They observed that the moths’ cuticle-producing cells transformed into salt-producing cells. Many such cases of natural transdifferentiation occur in organisms. In humans, pancreatic alpha cells can become beta cells. In newts, the loss of the eye’s lens causes the pigmented epithelial cells to transdifferentiate into the lens cells.
Artificial...
Artificial...
1.9K


